Breast cancer is the most common type of cancer affecting women, and is also the leading cause of cancer-related deaths among women worldwide. Characterised by uncontrolled growth of breast cells, breast cancer requires a specialised, comprehensive approach to treatment. At Artemis Hospitals, we understand the stress and anxiousness brought by one feels upon getting diagnosed with breast cancer, and ensure they have all the support they need at every step of their treatment journey. Combining cutting-edge diagnostic tools, advanced treatment options, and compassionate approach to care, our multidisciplinary team of oncologists, surgeons, and nursing staff ensures every patient receives the highest quality care.
Causes and Risk Factors for Breast Cancer
While the exact cause of breast cancer remains unknown, many factors are known to increase the risk of certain breast cancers. These include:
Age: The likelihood of someone developing breast cancer increases with age, particularly after the age of 50 years. Although younger women can also develop breast cancer, most cases are diagnosed in postmenopausal women.
Genetic Mutations: Certain inherited genetic mutations, especially in the BRCA1 and BRCA2 genes, significantly increase the risk. Affected individuals may face a lifetime risk as high as 70%, which is considerably higher than the general population.
Family History of Breast Cancer: A family history, especially involving first-degree relatives (mother, sister, or daughter) with breast cancer, is linked to a higher risk. The risk increases further if multiple family members have had breast or ovarian cancer.
Personal History of Breast Cancer: Individuals with a personal history of breast cancer in one breast have an increased risk of developing a new cancer in the other breast, and should go for screenings on a regular basis.
Specific Benign Breast Conditions: Certain non-cancerous (benign) breast conditions, such as atypical hyperplasia or lobular carcinoma in situ (LCIS), also increase the risk of breast cancer.
Dense Breast Tissue: Women with dense breast tissue, where there is a higher proportion of glandular and connective tissue compared to fatty tissue, are at a greater risk of developing breast cancer.
Hormone Replacement Therapy (HRT): Long-term use of hormone replacement therapy, particularly combined oestrogen and progesterone therapy, has been associated with an increased risk of breast cancer.
Early Onset of Menstruation and Late Menopause: Extended exposure to oestrogen, as seen in those who began menstruating before age 12 or who experience menopause after age 55, is linked to a higher breast cancer risk.
Reproductive History: Those who had their first pregnancy after the age of 30 years, and those who never had a child or breastfed, are at a slightly increased risk of developing breast cancer.
Exposure to Radiation: Individuals who have undergone radiation therapy at a young age, particularly to the chest area, have an increased risk of developing breast cancer later in life. The earlier the radiation exposure, the higher the risk.
Smoking: Long-term smoking, especially when starting at an early age, has been associated with certain types of breast cancer. Smoking may increase the risk through its effects on hormone levels and DNA, contributing to cellular changes linked to cancer.
In addition to the aforementioned, certain lifestyle factors can also increase the risk. These include
Alcohol Consumption: Research has consistently shown that alcohol intake increases breast cancer risk. The risk rises with the amount of alcohol consumed, and contrary to common notion, even moderate drinking has been linked to an elevated risk.
Obesity and Overweight: Being overweight, particularly after menopause, can increase the risk. After menopause, most oestrogen is produced by fat tissue, and higher levels of body fat can increase oestrogen levels, promoting cancer cell growth.
Sedentary Lifestyle: Regular exercise and physical activity have been shown to reduce breast cancer risk. A sedentary lifestyle, on the other hand, is associated with a higher risk, as physical activity helps regulate hormones, including oestrogen and insulin.
Recognizing these risk factors provides an opportunity for early interventions, lifestyle modifications, and regular screenings, especially for those who are at an elevated risk of developing breast cancer.
When to Consult a Doctor for Breast Cancer?
Be it any disease, the sooner it is diagnosed, the better are the outcomes of the treatment. Especially when it comes to a life-threatening disease such as breast cancer, the significance of identifying the early signs cannot be overstated. It’s advisable to consult a doctor if you notice any of the following signs or symptoms:
Lump or Thickening in the Breast or Underarm (Especially if it’s hard or painless)
Unexplained Changes in the Shape or Size of a Breast
Unexplained Discharge from the Nipple (Especially if it’s bloody)
Changes in Breast Skin (Dimpling, redness, or pitting)
A Sudden Inversion of the Nipple
Persistent Pain in Breast or Nipple Area
Even in the absence of any visible symptoms, it is recommended for women, especially those at a higher risk, to have regular screenings. Remember, early diagnosis can improve breast cancer treatment outcomes.
Types of Breast Cancer Treated at Artemis Hospitals
As a leading centre for breast cancer treatment and care, Artemis Hospitals offers specialised care for all types of breast cancer, ensuring that every patient receives the best possible treatment and care. Here are some of the types of breast cancer treated at Artemis Hospitals:
Invasive Ductal Carcinoma (IDC): Starts in the milk ducts and then spreads to surrounding tissue, potentially spreading to lymph nodes and other parts. Commonly treated with a combination of surgery, radiation, chemotherapy and targeted therapies.
Invasive Lobular Carcinoma (ILC): Originates in the milk-producing lobules and may spread to nearby lymph nodes or other body parts. This type can sometimes be difficult to detect on mammograms due to its unique growth patterns.
Ductal Carcinoma In Situ (DCIS): A non-invasive cancer where abnormal cells are confined within the milk ducts. DCIS has not spread into surrounding breast tissue and is typically treated with surgery and radiation, often with excellent outcomes.
Hormone Receptor-Positive Breast Cancer: Includes oestrogen receptor-positive (ER+) and progesterone receptor-positive (PR+) cancers, which rely on hormones to grow. Treatments, therefore, often include hormone-blocking medications.
HER2-Positive Breast Cancer: Identified by the overexpression of the HER2 protein, which promotes cancer cell growth. This type is more aggressive but responds well to certain targeted therapies that specifically block the HER2 protein.
Triple-Negative Breast Cancer (TNBC): Lacks oestrogen, progesterone, and HER2 receptors, making it unresponsive to hormone therapy or HER2-targeted treatments, but it often responds to chemotherapy, and in some cases, immunotherapy.
Inflammatory Breast Cancer (IBC): A rare and aggressive form of breast cancer that causes redness, swelling, and a warm sensation in the breast. Unlike most breast cancers, it does not usually form a lump; however, it requires immediate treatment.
Male Breast Cancer: Though rare, men can develop breast cancer, often as a lump or thickening near the nipple. Treatment in men generally follows the same protocols used in women, including surgery, radiation, and, if needed, hormone therapy.
Paget’s Disease of the Breast: A rare type of cancer involving the nipple and areola, often presenting symptoms such as itching, flaking, or redness of the nipple skin. It is frequently associated with underlying DCIS or invasive breast cancer.
Medullary Carcinoma: A rare subtype of breast cancer that often has a soft, fleshy consistency. Medullary carcinoma is sometimes linked with BRCA1 gene mutations and may respond well to surgery and radiation therapy.
Mucinous Carcinoma: Also known as colloid carcinoma, this rare type of breast cancer produces mucin, which forms a gelatinous tumour. Typically treated with surgery, mucinous carcinoma tends to grow more slowly and often has a favourable prognosis.
Metaplastic Breast Cancer: A very rare form involving multiple cell types, making it distinct from more common breast cancers. Metaplastic cancer often requires a combination of surgery, chemotherapy, and sometimes radiation.
Phyllodes Tumours: These tumours arise in the connective tissue of the breast and can be benign or malignant. Phyllodes tumours typically grow quickly and may require surgical removal, and close follow-up to prevent recurrence.
Angiosarcoma: A rare and aggressive cancer originating in the blood or lymph vessels in the breast. It can develop as a primary cancer or as a secondary cancer following radiation therapy. Treatment often includes surgery and may involve therapies.
Each treatment plan at Artemis Hospitals is designed with precision and care, offering patients the latest in medical expertise along with comprehensive support. Our focus is on delivering the highest quality of care while ensuring a compassionate experience for every patient and family member throughout their journey.
Diagnosis of Breast Cancer at Artemis Hospitals
The oncologists at Artemis Hospitals follow a comprehensive approach, combining advanced imaging, pathology, and expert analysis, ensuring accurate diagnosis and laying the foundation for the best possible treatment. Here’s a general overview of the our diagnostic process:
Clinical Examination: On the first visit of the patient, a specialist performs a thorough physical exam to check for any lumps, changes in breast tissue, or any other unusual signs that may indicate the presence of cancer.
Digital Mammography: The initial examination is typically followed by high-resolution mammograms to capture detailed images of the breast, identifying any abnormal growths or calcifications.
Ultrasound: Commonly used alongside mammography, ultrasound helps our specialists distinguish between solid tumours and fluid-filled cysts. At Artemis Hospitals we utilise the 4D Affinity 50 Ultrasound machine for breast ultrasounds.
Breast MRI: When other imaging tests are inconclusive, a breast MRI can be used to identify even any changes that may not be visible on mammograms or ultrasounds. Artemis Hospitals has cutting-edge 3 Tesla MRI for precise breast cancer diagnosis.
Biopsy: If imaging reveals any suspicious areas, a biopsy is performed to collect tissue samples for examination by our pathology team. We offer various biopsy options, including fine needle aspiration, core needle, and surgical biopsy.
Genetic Testing: For patients with a family history of breast cancer or those at higher risk, we offer genetic testing to check for mutations in specific genes, such as BRCA1 and BRCA2 - these genetic changes can increase the risk of breast cancer.
Pathology and Molecular Testing: Our pathology lab conducts detailed testing on biopsy samples to determine the cancer type, grade, and receptor status. Artemis Hospitals has a state-of-the-art VABB breast biopsy system for accurate diagnosis.
Staging and Additional Imaging: If cancer is detected, further imaging such as CT scans, PET scans, or bone scans may be recommended to assess whether the cancer has spread, allowing us to accurately stage the disease and plan the treatment.
Breast Cancer Treatments Available at Artemis Hospitals
Artemis Hospitals is equipped to offer a full spectrum of advanced breast cancer treatments, tailored to each patient’s unique diagnosis and medical needs. Key treatment options for breast cancer available at Artemis Hospitals include:
Breast Surgery
Surgery is one of the most common treatments for breast cancer. It involves removing cancerous tissue from the breast while preserving as much healthy tissue as possible. Artemis Hospitals offers several surgical options, tailored to the cancer type, size, and patient preferences:
Lumpectomy: Also known as “breast-conserving surgery”, this procedure involves removing the tumour along some of the surrounding tissue. It preserves most of the breast, and is typically followed by radiation therapy to minimise the risk of recurrence.
Mastectomy: A mastectomy can be considered in cases where a larger area of the affected breast or the entire breast needs to be removed. Our specialists are equipped to perform various types of mastectomies, including:
Total Mastectomy: Removal of the entire breast, including breast tissue, skin, and nipple.
Skin-Sparing Mastectomy: Preserves most of the breast skin, which can improve the appearance of breast reconstruction.
Nipple-Sparing Mastectomy: Removes only the breast tissue, sparing the skin, nipple, and areola for a more natural appearance after reconstruction.
Modified Radical Mastectomy: Commonly used if cancer has reached lymph nodes, this type of mastectomy involves removing the entire breast and some axillary lymph nodes to check for cancer spread.
Breast Reconstruction: For patients undergoing mastectomy, Artemis Hospitals provides reconstructive surgery options. Reconstruction may involve the use of silicone or saline implants, or tissue from another part of the body (Autologous Reconstruction).
Sentinel Lymph Node Biopsy: Often performed along with lumpectomy or mastectomy, this procedure identifies and removes the first lymph nodes to which cancer cells are likely to spread, allowing for targeted treatment.
Axillary Lymph Node Dissection: If cancer has spread to lymph nodes, additional lymph nodes in the armpit area may be removed to prevent further spread.
Each surgical approach is chosen based on factors such as cancer type, stage, and patient preferences. Artemis Hospitals’ surgical team combines precision with compassionate care, supporting patients through all stages of their surgical journey, from preparation to recovery.
Chemotherapy
Chemotherapy uses specialised drugs to target and destroy cancer cells throughout the body, making it an essential part of breast cancer treatment for many patients. At Artemis Hospitals, chemotherapy may be recommended based on the type, size, and stage of cancer, as well as individual patient factors. Our approach to chemotherapy includes but is not limited to:
Neoadjuvant Chemotherapy: Administered before surgery, this chemotherapy is used to shrink large tumours, making them easier to remove. It also increases the likelihood of successful breast-conserving surgery (lumpectomy) instead of a total mastectomy.
Adjuvant Chemotherapy: Administered after surgery, this aims to eliminate any remaining cancer cells, reducing the risk of recurrence. It is often recommended for patients with aggressive cancer types, larger tumours, or cancers that have spread to lymph nodes.
Systemic Treatment: Chemotherapy drugs are typically administered intravenously, allowing them to circulate through the bloodstream and reach cancer cells in various parts of the body. This is particularly useful for cancers with a higher risk of spreading or recurrence.
Combination Chemotherapy: In some cases, a combination of drugs is used to maximise effectiveness. The specific regimen, including drug type and dosage, is carefully selected based on the cancer’s characteristics and patient’s health.
Chemotherapy for Metastatic Cancer: For metastatic breast cancer, chemotherapy can help control the disease, manage symptoms, and improve quality of life. The treatment plan is adjusted to meet the patient’s specific needs, balancing effectiveness with side-effect management.
Supportive Care: At Artemis Hospitals, we prioritise patient comfort and support during chemotherapy, and provide anti-nausea medications, immune-supporting therapies, and guidance on managing side effects such as hair loss, fatigue, and digestive issues.
Artemis Hospitals’ chemotherapy services are delivered by a highly trained team of oncologists and oncology nurses. Each patient’s chemotherapy plan is personalised to optimise outcomes and minimise side effects, ensuring the highest possible quality of care.
Radiation Therapy
Radiation therapy is a targeted treatment that uses high-energy rays to destroy cancer cells in specific areas. At Artemis Hospitals, radiation therapy is used as a part of breast cancer treatment, especially after surgery to reduce the risk of recurrence. Our approach includes:
External Beam Radiation Therapy (EBRT): The most common type of radiation therapy for breast cancer, where a machine directs precise beams of radiation to the affected area. Typically, EBRT is used after a lumpectomy or mastectomy to target any remaining cancer cells.
Brachytherapy (Internal Radiation): This form of localised radiation involves placing radioactive material directly into or near the tumour site, delivering radiation from within the breast. Brachytherapy is usually done over a shorter period than EBRT and is particularly useful for early-stage breast cancers, often following a lumpectomy.
3D Conformal Radiation Therapy (3D-CRT): Uses advanced imaging to create a three-dimensional view of the tumour area, allowing for precise targeting of the cancer, while sparing nearby healthy tissues as much as possible. This method minimises side effects and is often used for patients with complex tumour shapes or locations.
Intensity-Modulated Radiation Therapy (IMRT): IMRT allows for varying radiation doses across different parts of the treatment area, focusing a higher dose on the tumour while reducing exposure to surrounding healthy tissue. This precision is beneficial in cases where the tumour is close to vital structures.
Hypofractionated Radiation Therapy: A newer approach, hypofractionated radiation delivers higher doses over fewer sessions, often completing treatment within 3 to 4 weeks instead of the traditional 6 weeks. This option is effective for certain early-stage breast cancers and offers convenience without compromising efficacy.
Radiation for Metastatic Breast Cancer: In cases where breast cancer has spread to bones, brain, or other areas, radiation therapy may be used to relieve symptoms and improve quality of life. This palliative approach focuses on controlling pain and slowing disease progression.
Skin Care and Support During Radiation: The radiation oncology team at Artemis Hospitals provides specialised support for managing common side effects, such as skin redness, soreness, and fatigue. Patients receive guidance on skincare, nutrition, and self-care practices to help ease discomfort during treatment.
Artemis Hospitals’ radiation oncology team uses advanced technology and individualised treatment plans to maximise the effectiveness of radiation therapy while minimising side effects. This precision-focused approach supports both the eradication of cancer cells and the patient’s overall well-being.
Immunotherapy
Immunotherapy is used to stimulate or boost the body’s own immune system to recognize and fight cancer cells. At Artemis Hospitals, immunotherapy is primarily used for specific types of breast cancer that are more resistant to traditional treatments. Our immunotherapy options include:
Checkpoint Inhibitors: These drugs work by "releasing the brakes" on the immune system, allowing it to recognize and attack cancer cells. For example, the drug pembrolizumab (Keytruda) is often used for metastatic triple-negative breast cancer that expresses the PD-L1 protein. Checkpoint inhibitors can be used alone or in combination with chemotherapy.
Monoclonal Antibodies: Monoclonal antibodies are lab-made molecules that target specific proteins on cancer cells, marking them for the immune system to attack. While more commonly used in other cancers, these are being explored and, in some cases, used for advanced breast cancers.
Combination Immunotherapy: For certain aggressive breast cancers, combining immunotherapy with chemotherapy or targeted therapies has shown promising results, particularly in improving survival rates. This approach is often personalised based on tumour characteristics and patient health.
Cancer Vaccines: Currently, cancer vaccines are mostly in the clinical trial phase, but they aim to stimulate the immune system to recognize breast cancer cells as threats. Artemis Hospitals participates in clinical trials, offering eligible patients access to experimental vaccines and other advanced immunotherapy treatments.
Personalized Immunotherapy Trials: Artemis Hospitals offers patients access to clinical trials that explore the latest immunotherapy advancements. Through personalised trials, patients may benefit from tailored therapies not yet widely available, such as CAR-T cell therapy, which re-engineers the patient’s immune cells to target breast cancer cells.
Immunotherapy at Artemis Hospitals is delivered by a dedicated oncology team skilled in the latest advances, offering a promising option for breast cancer patients with specific tumour types or those seeking alternatives to conventional treatments. Each immunotherapy plan is customised to optimise the patient’s immune response while supporting their overall health and quality of life.
Hormone Therapy
Hormone therapy, also known as endocrine therapy, is a highly effective treatment for hormone receptor-positive (HR+) breast cancers, which rely on oestrogen or progesterone to grow. The specialists at Artemis Hospitals use hormone therapy to block or reduce the body’s hormone levels, slowing cancer growth and reducing the risk of recurrence. Key approaches include:
Selective Oestrogen Receptor Modulators (SERMs): SERMs are drugs that block oestrogen receptors on breast cancer cells, preventing oestrogen from stimulating tumour growth. Tamoxifen is prescribed to both pre- and postmenopausal women, typically over a course of 5-10 years to reduce the risk of recurrence.
Aromatase Inhibitors: For postmenopausal women, drugs such as anastrozole, letrozole, and exemestane are used to lower oestrogen levels by inhibiting the enzyme aromatase, which converts other hormones into oestrogen. Aromatase inhibitors are often prescribed for 5 years or more, depending on the cancer’s risk level.
Ovarian Suppression: In premenopausal women with high-risk breast cancer, ovarian suppression therapy may be recommended to reduce oestrogen production. This can be achieved through medications or surgical removal of the ovaries (oophorectomy). Ovarian suppression is often used with hormone therapies to enhance effectiveness.
Selective Oestrogen Receptor Degraders (SERDs): These are drugs that bind to and degrade oestrogen receptors on cancer cells, preventing them from responding to oestrogen. SERDs are typically used in advanced breast cancer cases and are administered as injections, often in combination with other treatments.
Combination Hormone Therapy: In some cases, combining hormone therapy drugs can provide more effective treatment, especially in advanced or metastatic breast cancer. This combination approach helps to disrupt multiple pathways that cancer cells use to grow, increasing treatment efficacy.
Adjuvant and Neoadjuvant Therapy: Hormone therapy can be used after surgery (adjuvant) to prevent recurrence or before surgery (neoadjuvant) to shrink tumours, making surgery more effective. The timing and type of hormone therapy are carefully chosen based on cancer characteristics and patient factors.
Artemis Hospitals’ oncology team closely monitors patients during hormone therapy, managing potential side effects like hot flashes, bone thinning, and joint pain to ensure the best outcomes. By tailoring hormone therapy to each patient’s specific needs, we help maximise effectiveness while supporting overall well-being.
Targeted Therapy
Targeted therapy is a cancer treatment that specifically targets proteins or genetic mutations involved in cancer cell growth, offering a more precise approach than traditional chemotherapy with potentially fewer side effects. At Artemis Hospitals, targeted therapy is used to treat specific types of breast cancer, such as HER2-positive and hormone receptor-positive cancers, providing a more focused alternative to traditional chemotherapy with fewer side effects. Key targeted therapies include:
HER2-Targeted Therapy: HER2-positive breast cancer cells produce an excess of the HER2 protein, which promotes rapid cell growth. Targeted drugs for HER2-positive cancer include:
Trastuzumab (Herceptin): A monoclonal antibody that binds to HER2 receptors on cancer cells, slowing their growth and marking them for immune system destruction. It is often given with chemotherapy for greater efficacy.
Pertuzumab (Perjeta): Used in combination with trastuzumab, pertuzumab further blocks HER2 activity and is effective in treating advanced HER2-positive breast cancer.
Ado-Trastuzumab Emtansine (Kadcyla): This drug combines trastuzumab with chemotherapy, directly delivering cancer-killing agents to HER2-positive cells while minimising damage to healthy cells.
Lapatinib and Neratinib: These are oral tyrosine kinase inhibitors that block HER2 activity inside the cancer cell, offering an option for patients with advanced HER2-positive cancer.
CDK4/6 Inhibitors: For hormone receptor-positive, HER2-negative breast cancers, drugs such as palbociclib, ribociclib, and abemaciclib are used to inhibit CDK4 and CDK6 proteins, which are essential for cancer cell division. These drugs are typically combined with hormone therapy to enhance treatment effectiveness.
PI3K Inhibitors: For patients with advanced hormone receptor-positive breast cancer that has a specific PIK3CA gene mutation, alpelisib (Piqray) is a targeted therapy that blocks the PI3K protein, a driver of cancer growth. When combined with hormone therapy, PI3K inhibitors can improve outcomes for patients with this mutation.
mTOR Inhibitors: Everolimus (Afinitor) is an mTOR inhibitor used for hormone receptor-positive, HER2-negative breast cancers that no longer respond to hormone therapy alone. It helps prevent cancer cells from using the mTOR pathway to grow, making hormone therapy more effective.
Antibody-Drug Conjugates (ADCs): ADCs are a newer class of targeted therapies that link a chemotherapy drug to an antibody. This approach allows the antibody to deliver chemotherapy directly to cancer cells, sparing normal cells. Examples include T-DM1 (Kadcyla) for HER2-positive cancers and sacituzumab govitecan (Trodelvy) for triple-negative breast cancer.
PARP Inhibitors: For patients with inherited BRCA1 or BRCA2 gene mutations, PARP inhibitors like olaparib (Lynparza) and talazoparib (Talzenna) interfere with the cancer cell’s DNA repair mechanisms, leading to cell death. This is particularly effective in advanced HER2-negative breast cancer cases associated with BRCA mutations.
Hormone Receptor-Targeted Therapies: While not traditional targeted therapies, hormone-targeting drugs like SERMs and aromatase inhibitors specifically target oestrogen or progesterone receptors on cancer cells. These drugs are highly effective for hormone receptor-positive cancers and often combined with other targeted treatments for added impact.
Artemis Hospitals’ oncologists use advanced diagnostic tools to identify the most effective targeted therapies based on each patient’s cancer profile, enhancing treatment precision and minimising side-effects.
Why Choose Artemis Hospitals for Breast Cancer Treatment
Choosing a hospital for breast cancer treatment is a life-defining decision, which decides the patient’s experience during the treatment as well as their path to recovery. At Artemis Hospitals, we understand the gravity of this choice and are dedicated to providing not only advanced medical expertise but also compassionate support and guidance at every step. Here are a few attributes that make Artemis Hospitals a trusted name for breast cancer treatment:
Comprehensive Care: A full range of breast cancer services, from diagnosis to advanced treatment options, ensuring seamless continuity of care.
Multidisciplinary Team: Highly experienced oncologists, surgeons, radiologists, and nursing staff, who collaborate to ensure our patients receive the best possible care.
Advanced Diagnostic Capabilities: High-resolution mammography, ultrasound, MRI, and genetic testing for precise diagnosis and risk assessment.
Latest Treatments: Access to state-of-the-art treatments such as targeted therapy and immunotherapy.
Personalised Treatment Plans: Each treatment plan is tailored to the patient’s specific cancer type and stage for optimal results.
Supportive Care and Counseling: Dedicated support services, including nutrition, pain management, and counselling, to enhance quality of life during and after treatment.
Clinical Trials Access: Eligible patients have access to clinical trials, offering potential cutting-edge treatments not yet widely available.
At Artemis Hospitals, we bring together medical expertise, technology, and compassionate care to offer the best treatment for breast cancer.
Book a Consultation with a Breast Cancer Specialist Today!
Artemis Hospitals, ranked among the best breast cancer hospitals in Gurgaon, India, is leading the way in breast cancer treatments. Our mission is to provide holistic care for breast cancer patients, starting from initial assessment and diagnosis, all the way to post-treatment follow-ups and long-term care. Whether you are looking for the latest treatment options for breast cancer or an expert’s opinion on breast-related abnormalities, your search ends here. To book a consultation with a breast cancer specialist at Artemis Hospitals, you can call us at +91-124-451-1111, WhatsApp at: +91-95992-85476, or register on our Online Patient Portal. You can also download and register on our Artemis Personal Health Record mobile app, available for both iOS and Android devices.
